Alzheimer's population to hit 63M in Asia
A study by the US Johns Hopkins University has revealed that the worldwide number of Alzheimer's disease sufferers is expected to quadruple by the year 2050. The biggest regional increase is forecast to be in Asia, with the existing 12.6 million cases rising almost fivefold to 62.8 million by the middle of the 21st century.
AD explosion if no treatment advances
The study, funded by Ireland-based biotechnology firm Elan Pharmaceuticals and US drug major Wyeth Pharmaceuticals, is a "reminder of the toll to come" if not enough progress is made by the research-based drugmakers and other scientific research centers into AD, the Associated Press reports.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze